3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
15
Breast Neoplasms
13
Ovarian Neoplasms
5
Stomach Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Small Cell Lung Carcinoma
3
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Uterine Cervical Neoplasms
2
Neoplasms
2
Melanoma
2
Advanced Pancreatic Cancer
2
Thoracic Neoplasms
1
Stage IA Pancreatic Adenocarcinoma
1
Squamous Cell Carcinoma of Lung
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Second Line Treatment of Gastric Cancer
1
Sarcoma
1
Resectable Biliary Tract Cancer
1
Pathologic Complete Response
1
Pancreatic Adenocarcinoma
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscle-Invasive Bladder Carcinoma
1
Lung Diseases
1
HR+/HER2- Breast Cancer
1
HER2+ Breast Cancer
1
Interventions
Trastuzumab
2
toripalimab
1
pyrotinib
1
Vinblastine
1
Transurethral Resection of Bladder
1
Thalidomide
1
TP protocol
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Metformin
1
Magnetic Resonance Imaging
1
Immunohistochemistry
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Cisplatin
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Carboplatin
1
Bortezomib
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pathologic Complete Response
×
Albumin-Bound Paclitaxel
×
Clear all
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled